Skip to main content
Explore URMC

menu

Preemie Hypothermia for Neonatal Encephalopathy

Research Question:
Does hypothermia help treat premature infants who have encephalopathy?

Basic Study Information

Purpose:
Encephalopathy is a general term that means brain disease, damage, or malfunction. This study is a randomized, controlled trial to assess safety and effectiveness of whole body hypothermia for 72 hours in preterm infants 33-35 weeks gestational age (GA) who present at <6 hours postnatal age with moderate to severe neonatal encephalopathy (NE). The study will enroll infants with signs of NE at 18 NICHD Neonatal Research Network sites, and randomly assign them to either receive hypothermia or participate in a non-cooled control group.

Location: University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher: Carl D'Angio

Study Contact Information

Study Coordinator: Carl T D'Angio, MD
Phone: (801) 581-7052

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search